“Burza cytokin” w przebiegu COVID-19: krytyczna analiza

Pratik Sinha i wsp. Is a “Cytokine Storm” Relevant to COVID-19? JAMA Intern Med. Published online (dostępny pełen tekst)

Although the mechanisms of COVID-19–induced lung injury are still being elucidated, the term cytokine storm has become synonymous with its pathophysiology, both in scientific publications and the media. Absent convincing data of their effectiveness in COVID-19, drugs such as tocilizumab and sarilumab, which are monoclonal antibodies targeting interleukin (IL)-6 activity, are being used to treat patients; trials of these agents typically cite the cytokine storm as their rationale. A critical evaluation of the term cytokine storm and its relevance to COVID-19 is warranted …

Jama Internal Medicine, 30 czerwca 2020

Dodaj komentarz